Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Stomach Neoplasms 3Malnutrition 2Carcinoma, Hepatocellular 2Psychological Well-Being 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Gastrointestinal Neoplasms 1Fibrosis 1Esophageal Neoplasms 1Endotoxemia 1Diarrhea 1Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Fluorouracil 26Radiotherapy 18Mitomycin 17Cisplatin 12Capecitabine 12pembrolizumab 10Magnetic Resonance Spectroscopy 9Cyclophosphamide 9Radiation 8Paclitaxel 8Biopsy 8fludarabine 7Specimen Handling 7Nivolumab 7Drug Therapy 7Carboplatin 7Surveys and Questionnaires 6Cetuximab 6Papillomavirus Vaccines 5dehydroftorafur 4aldesleukin 4Vaccines 4Radiotherapy, Intensity-Modulated 4Observation 4Irinotecan 4Watchful Waiting 3Taxes 3Oxaliplatin 3Light Coagulation 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Probiotics × Gastrointestinal × Clear all
NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown
75 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡